FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s - fda.gov

The U.S. Food and Drug Administration today announced the issuance of 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites.